0000914475-24-000080.txt : 20240229
0000914475-24-000080.hdr.sgml : 20240229
20240229185029
ACCESSION NUMBER: 0000914475-24-000080
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240227
FILED AS OF DATE: 20240229
DATE AS OF CHANGE: 20240229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Norwalk Leslie V
CENTRAL INDEX KEY: 0001533568
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 24706126
MAIL ADDRESS:
STREET 1: C/O 3661 VALLEY CENTRE DRIVE SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 330525145
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
wk-form4_1709250595.xml
FORM 4
X0508
4
2024-02-27
0
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001533568
Norwalk Leslie V
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
1
0
0
0
1
Common Stock
2024-02-27
4
M
0
8000
84.95
A
8000
D
Common Stock
2024-02-27
4
S
0
8000
135.6735
D
0
D
Non-Qualified Stock Option
84.95
2024-02-27
4
M
0
8000
84.95
D
2032-05-18
Common Stock
8000
1724
D
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 28, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $134.82 to $136.50. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Option vests in 12 monthly installments beginning June 18, 2022.
/s/ Darin Lippoldt, Attorney-in-Fact
2024-02-29